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Cross-Cultural applicability of the Montreal Cognitive Assessment (MoCA): a 
systematic review  
 
Abstract 
The MoCA is  widely used to screen for mild cognitive impairment. While there are 
many available versions, the cross cultural validity of the assessment has not been 
explored sufficiently.  
We aimed to interrogate the validity of the MoCA in a cross-cultural context: in 
differentiating mild cognitive impairment (MCI) from normal controls (NC); and 
identifying cut-offs and adjustments for age and education where possible. This review 
sourced a wide range of studies including case-control studies. In addition, we report 
findings for differentiating dementias from NC and MCI from dementias, however, 
these were not considered to be an appropriate use of the MoCA.  
The subject of the review assumes heterogeneity and therefore meta-analysis/es was 
not conducted. Quality ratings, forest plots of validated studies (sensitivity and 
specificity) with covariates (suggested cut-offs, age, education and country) and 
summary received operating characteristic curve (sROC) are presented.     
The results showed a wide range in suggested cutoffs for MCI cross culturally, with 
variability in levels of sensitivity and specificity ranging from low to high. Poor 
methodological rigour appears to have affected reported accuracy and validity of the 
MoCA.  
The review highlights the necessity for cross cultural considerations when using the 
MoCA, and recognizing it as a screen and not a diagnostic tool. Appropriate cutoffs 
and point adjustments for education are suggested.  
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Introduction  
Mild cognitive impairment (MCI) is conceptualized as a transitional stage between 
normal aging and dementia and is recognized as a risk factor for AD [1], prompting 
many researchers to screen for MCI in order to provide early treatment and reduce the 
risk of progression to dementia [2]. Transitional markers from MCI to dementias are 
challenging to define and cognitive impairment may result from conditions not related 
to dementia (e.g. delirium, substance use, psychiatric illness and metabolic 
conditions). Factors including high premorbid intellectual function, high quality 
occupational and educational attainment; are suggested to provide a 'cognitive 
reserve' [3] conserving existing cognitive abilities even in the presence of biological 
risk.  Due to the lack of stable biomarkers of neurodegeneration [4,5] diagnosis is 
reliant on clinical judgment, defined by clinical, cognitive, and functional criteria.  
Broadly, criteria for MCI relate to concern regarding a change in cognition, impairment 
in one or more cognitive domains and preservation of independence in functional 
abilities [6], however differences in clinical definitions exist [6,7] with clinical subtypes 
such as amnestic and non-amnestic MCI, and MCI due to deficits in single and multiple 
cognitive domains [8]. Indeed, MCI does not necessarily indicate a progressive 
degeneration with reversion rates from MCI to NC estimated at approximately 18% [9] 
and stability rates between 37% to 67% [10]; higher than rates of progression to 
dementia. Wide variation of incidence and prevalence rates exists for subtypes of  MCI  
([11,12], related to the differences in diagnostic criteria applied and how they are 
operationalized (e.g. cognitive assessments used, cut-offs for age and education) [11]. 
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To facilitate the detection of MCI, many health professionals around the world are 
using the Montreal Cognitive Assessment (MoCA) as a brief cognitive screen across 
a variety of clinical settings. The MoCA, developed and validated by Nasreddine et al. 
[13], is a brief and potentially useful screening tool with high sensitivity and specificity 
for detecting MCI in persons performing in the normal range on the Mini-Mental State 
Examination (MMSE). It has been translated into 36 languages and additional 
alternative forms, yet only a small number have been validated and nearly all versions 
lack population-based data of individuals aged 80-plus [14]. For instance, the norms 
and cut-off scores for MCI and dementia of the MoCA are different among five Chinese 
versions [14] and the cut-off of 26 (+1 for <12 years education; recommended in the 
original study), has been suggested on many forms without validation. 
 
Cross cultural cognitive assessment 
Cultural factors (i.e. the accumulation of shared knowledge, reflected in behaviours,  
experience, beliefs, values, attitudes: [15]) and lifestyle factors (i.e. pattern of everyday 
life given available resources e.g. employment, diet, activities, living arrangements; 
[16]) will vary across and within groups.  Education can be considered an aspect of 
culture where learning and schooling is embedded with the culture [17]. Culture may 
affect the validity of the cognitive tests used to identify MCI through biases related to 
the test or administration. For instance, where the construct an item is measuring is 
ambiguous due to poor translation or lack of cultural equivalent, or where there is 
unfamiliarity with both testing and stimuli or the related skill does not exist within a 
cultural repertoire [18]. 
 
Because of cultural background and lifestyle differences in Eastern and Western 
countries, it is necessary to assess the scale in patients from different cultures.  The 
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MoCA is a screening instrument that evaluates seven cognitive domains on a single 
page and scores range from 0 to 30[13]. The domains are: visuospatial/executive 
functions, naming, verbal memory registration and learning, attention, abstraction, 5-
minute delayed verbal memory, and orientation. Validation of the MoCA in different 
languages has led to linguistic and cultural modifications. For instance, in the Filipino 
version of the MoCA, an owl, the image that locals can recognize, is used as the 
replacement of rhinoceros [19]. The Chinese Beijing Version for example replaced 
Roman alphabets with Chinese character sequences in Alternating Trail Making and 
the names were changed to more common Chinese names to reflect local familiarity 
in the sentence repetition [20]. In the Korean version it is notable that the phonemic 
fluency task is replaced with a semantic fluency task [21]. Considering that frequency 
of phonemes may differ across languages, the scores of phonemic fluency task are 
not transferable from one country to another [22]. Indeed, the format for some cultures 
has been drawn into question, for instance trail making and cube copying test may be 
unfamiliar [23] and sentence repetition where revisions are not considered may not be 
equivalent becoming overly complex in translation. In contrast some items in the 
English version may not be sensitive enough, for instance Chinese speakers tend to 
perform better on digit span tasks [24]. 
Issues of normal variability in cognitive functioning. for instance, individuals at the polar 
ends of a normal distribution (e.g. 6% of healthy people will score at or below 1.5 
standard deviations below the norm), may lead to a misclassification -false positive 
(FP) or false negative (FN)- based on a cut off. A normative approach was attempted 
by Wong et al [25] using the MOCA (Hong Kong version) and estimated high FP rates 
among NC  highlighting the elevated risk of misclassification when using cut offs 
especially for those older and less educated.  
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The use of universal cut-offs also leads to a sampling bias (i.e. sample for which the 
cut off was established does not match with the individual being assessed) which, if 
uncontrolled, leads to false conclusions about an individual’s cognitive ability. This 
may not relate to the cognitive test itself, but how a health care professional may 
interpret these results and how this may inform clinical decision making. A 'diagnostic 
cut-off' suggests that the cut-off alone can be used to interpret the MoCA rather than 
considering other factors affecting performance, or being aware that the MoCA is a 
screen and does not replace more thorough diagnostic assessment. However, where 
resources and training are limited, there may be a reliance on tools which are cost and 
time effective.  Therefore, education and culturally adjusted ‘cut-offs’ can inform 
clinical decision making.  Furthermore, different domains of cognition have cultural and 
language loadings. Language and literacy vary within and across cultures and will 
affect measurement of attention and memory. Performance on tests assessing 
executive functions are strongly related to education and culture [26,27] associated to 
processes of learning, language skills; perceptual skills and reasoning. As a 
consequence, individuals are unlikely to perform consistently across the MoCA due to 
factors other than cognitive decline. Even where the individual may speak English (and 
tested in English), English proficiency and language and cultural acculturation, may 
affect performance. In addition, adjustments to assessment, for instance using an 
interpreter introduces additional methodological issues.  
Studies have demonstrated that the culturally and linguistically adapted versions of 
the MoCA are superior to the MMSE in screening for MCI [20,28,29], however, due to 
the differences in Western culture and difficulty in separating the influence of culture 
from education level, further revision of MoCA adaptations are required to tailor the 
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contents more accurately to local populations across the globe as well as optimizing 
cut-offs for detecting MCI. 
 
Rationale 
We aim to explore the cross cultural applicability of the measure and suggested cut-
offs in more detail.  Given that the MoCA is regularly used as a reference standard 
(i.e. selected as the measure against which other tests are evaluated or to inform 
classification), we aim to highlight considerations specific to language, cultural regions, 
age and education when using this measure clinically and as a research tool especially 
when assessing non western - English speaking individuals.  
 
The MoCA was originally validated to identify MCI [13]. Due to the variation in 
classification there is no universally accepted “gold standard” criterion for diagnosis of 
MCI. As such this review considers the validations of the MoCA for MCI against 
recognised diagnostic criteria outlined in the inclusion criteria.  
Data differentiating between MCI and dementia, and between dementia and NC are 
presented, however, these were considered to have limited utility. Cognitive screens 
alone should not be used in isolation to diagnose dementia. Guidelines [30,31]indicate 
the need for  comprehensive physical, medical and cognitive assessment and history 
taking when it comes to diagnosing forms of dementia. Differentiating MCI and 
dementia is informed by identification of cognitive decline interfering with performing 
complex activities. The same applies to differentiating dementia from NC. None the 
less, dementia diagnosis based on MoCA has recently been reviewed [32], suggesting 
the quality of the studies was “not good enough” to conclusively recommend its use 
and that a lower cut-off was likely to be more accurate. While the review reported 
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optimal sensitivity and specificity due consideration was not given to education or 
variation in suggested cut-offs.  Many studies have emerged since their search in 
2012, and from a cross cultural perspective, given that these studies are validating the 
MoCA in different populations, these data have been included for reference.    
 
Methods 
The review protocol was registered with PROSPERO (registration no. 
CRD42016032837). Review followed PRISMA guidelines [33].  
 
Search method for inclusion of studies  
Published and unpublished studies were considered, no language or date restrictions 
were applied. Search terms were compiled into two concepts 1. (Montreal adj cognitive 
adj assessment) or MoCA 2. validat$ or norm$ or adapt$ or translat$ or cultur$ or 
reliab$). 
Searches were conducted using the following databases: Ovid MEDLINE In-Process 
& Other Non-Indexed Citations and Ovid MEDLINE, Ovid PsycINFO and Ovid Embase 
(all years to 09 January 2016). Articles citing the original MoCA paper [13] were 
screened separately using Google Scholar.  
 
Inclusion / Exclusion criteria  
Criteria for inclusion of studies in the review were (1)dementia or MCI with comparison 
group, (2)more than 10 cases in each group, and (3)use of MoCA compared with a 
reference standard. The reference standard was defined as the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) versions III to 5 [34], International 
Classification of Diseases – 10th edition (ICD-10) [35], the National Institute of 
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Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease 
and Related Disorders Association Alzheimer's criteria (NINCDS-ADRDA) [36], 
Petersen's criteria [37], National Institute of Neurological Disorders and Stroke and 
Association Internationale pour la Recherché et l'Enseignement en Neurosciences 
(NINDS-AIREN) [38]or expert diagnosis following interview such as the Clinical 
Dementia Rating (CDR) [39].  
Studies were exclude where MoCA score was used as a grouping variable, (2) where 
studies investigated English speaking, western samples and (3) where there was 
evidence of co-morbid mental health conditions e.g. schizophrenia, in the samples.  
 
Selection of studies   
Review authors independently reviewed titles and abstracts for inclusion criteria. Any 
questions regarding eligibility were resolved by seeking additional information from 
study authors and through discussion with the other author. Fig. 1. outlines a PRISMA 
flow diagram of the systematic review. 
 
Insert Figure 1: PRISMA flow diagram of the systematic review. 
 
Data extraction 
From the selected papers, the following data were extracted: population, recruitment 
strategy, specification of illness, comparator (diagnostic standard), age, country, 
education adjustments, cut-off score, sensitivity and specificity (full details in 
supplementary data). Study authors were contacted for additional information where 
necessary. Reasonable attempts were made to translate papers to English (authors 
sought out translation by native speakers within their affiliated institutions).  
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Risk of bias across studies 
Review authors independently assessed the methodological quality of the included 
studies using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) 
instrument [40], designed to evaluate the risk of bias and applicability of diagnostic 
accuracy studies.  Any disagreements were decided by consensus. 
 
The methodological quality in each of the domains (patient selection, execution of the 
index test and the reference standard, and flow of patients) was often difficult to assess 
as the required information was not clearly stated in the published reports. The 
QUADAS-2 scores for each domain and for each sub analysis are included 
(Supplementary Figure 1, 2 and 3), a summary is present in Figure 2. 
 
 
Insert Figure 2: Risk of bias and applicability concerns graph: review authors’ 
judgments about each domain presented as percentages across included studies 
 
 
For Patient Selection, case-control design studies were included for all analyses, 
where controls were thought to be a representative sample of the population which 
produced the cases. However, the case control design leads to spectrum bias (where 
sensitivity or specificity of the test differs with different patient characteristics or 
disease features e.g. severity) resulting in overestimation of test accuracy, which 
therefore resulted in a high risk of selection bias (differences between baseline 
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characteristics of the groups that are compared) and is recognised as a source of 
heterogeneity in this review.  
 
In the Index Test domain over half of the studies were judged as being of unclear risk 
of bias, mainly due to the absence or unclear reporting on test administration, masking 
and pre-specification of thresholds. These studies were considered to have low risk of 
concerns about applicability.  
 
In the Reference Standard domain all studies used a recognised reference standard 
that was likely to correctly classify the condition. However, the studies marked as 
unclear did not report the use of masking clearly and/or how the reference standard 
was operationalised and applied. Over 85% of the studies were assessed as being of 
low risk of concern about applicability. 
 
In the Flow and Timing domain, less than a quarter of studies were judged as unclear, 
mainly due to absence of relevant information about the time intervals between index 
tests and reference standards and a lack of reporting about whether all participants 
were included in the final analyses.  
 
Data Synthesis  
Sensitivity, specificity for optimal cut offs (as indicated by the study authors) and 
sample size data were extracted into Review Manager 5.2 [41] for analysis. Where 
data were stratified to account for education or age we selected these data. Where 
exact sample sizes were not specified the whole group sample was divided for both 
groups (clinical and control). Analyses were separated into three categories: 
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differentiating MCI from NC, differentiating MCI from dementia, and differentiating 
dementia from NC. True (TP) and false (FP) positives, and true (TN) and false (FN) 
negatives were calculated for all studies. Sensitivity and specificity with 95% 
confidence intervals are presented separately for MCI and dementias. 
Given the majority of studies were case control studies, accurate estimates of 
prevalence could not be calculated, limiting further analyses. To overcome the 
heterogeneity due to cut-offs, the accuracy data were pooled by fitting a summary 
received operating characteristic curve (sROC). 
 
Results 
 
Insert Figure 3: sROC curve for studies differentiating between MCI and NC. 
 
Insert Figure 4: Forest plot for differentiating between MCI and NC. 
 
MCI vs. NC  
 
Twenty six studies in total (N=19060) investigated the ability of the MoCA to 
differentiate MCI from NC. Sensitivity ranged from 55% (at a specificity of 76%) to 96% 
(at a specificity of 76%). Specificity ranged from 19% (at sensitivity of 96%) to 97% (at 
sensitivity of 91%). A symmetrical sROC curve was generated with studies given equal 
weight for analysis (Figure 3). Studies, covariates and forest plots are presented in 
Figure 4.   
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While the number of studies and variation with the regions affect pooling of data, we 
divided up the studies into geographical regions to summarize the descriptive data. It 
does not suggest homogeneity between regions. Where indicated in the studies, 
education or age adjustments are reported.  
 
China, Malaysia and Taiwan  
 
Thirteen studies (N=16972) were validated across Chinese and Malay cohorts 
differentiating MCI from controls. These regions have been combined due to cross 
over in ethnicities involved in these studies. There were a number of validated adapted 
versions of the MoCA for this region: Beijing, Cantonese, Changsha, Hong Kong and 
Singapore. Suggested cut-offs ranged from 13 to 26 to differentiate MCI from NC. Two 
studies employing large samples, suggest age [14] and education [23] adjusted cut 
offs. Only one study investigated vascular cognitive impairment [42] suggesting a 
cutoff 26/27. Sensitivity ranged from 55% (at a specificity of 76%) to 96% (at a 
specificity of 76%). Specificity ranged from 62% (at sensitivity of 75%) to 97% (at 
sensitivity of 91%).  
 
Lu et al. (2011) [23] noted significant effects of education, age, urban or rural 
residence, and sex on MoCA scores. Zhou et al. (2014) [43] raised concerns about 
applicability of MoCA-Cantonese in their low education sample (sensitivity: 49%). A 
number of studies retained the original suggestion of 1 point adjustment for <12 years 
education [14,23,43–47]. An education adjustment for <6years of 1 point was made 
by a number of studies [20,42,48,49] while Tan et al [14]  suggested a 2 point 
adjustment for ≤6 years of education and Chu et al. [48] 2 points for illiteracy. 
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Two studies (N=489) specifically investigated the MoCA-Singapore [50,51] both 
adjusted cut-offs for education at different levels however accuracy levels were poor 
with high FP and FN. Sensitivity ranged from 54% (at a specificity of 51%) to 96% (at 
a specificity of 31%). Specificity ranged from 19% (at sensitivity of 96%) to 57% (at 
sensitivity of 59%).  
The MoCA-Taiwan was only validated to differentiate between dementia and NC.  
 
South East and Southern Asia (Japan, Korea, Philippines, Sri Lanka, Thailand) 
 
One study (N=66) differentiating MCI from controls in Japan [52] suggested a cut off 
of 25/26, in an educated sample, no education adjustment was used. One study 
(N=85) in Thailand [53], suggested a cut off of 24/25 in a poorly educated sample. One 
study (N=152) in Korea [21] suggested a cutoff of 22/23 with a 1 point adjustment for 
<6 years of education. Julayanont et al [53] made an adjustment of 1 point for < 4 
years education and an additional 1 point for meeting the illiteracy criteria. All studies 
displayed high sensitivity and specificity, but these results were based on small 
samples. 
The MoCA- Philippines and the MoCA- Sri Lanka were only validated to differentiate 
between dementia and NC. 
 
Europe (Germany, Holland, Poland, Portugal)  
One study from each region (N=639) validated the MoCA differentiating MCI from 
controls. Where education level was broadly comparable the suggested cutoffs were 
25/26, in the lower education Portuguese sample [28] the suggested cut off was 22. 
 14 
Sensitivity ranged from 72% (at a specificity of 73%) to 93% (at a specificity of 62%). 
Specificity ranged from 54% (at sensitivity of 81%) to 77% (at sensitivity of 81%).  
While the Polish [54] and German [55] studies retained the original 1 point adjustment, 
the Dutch study [56] implemented a 2 point adjustment for ≤ 12 years of education. 
Freitas et al. [23] did not include an adjustment for their sample.  
Additionally, high FP rates were noted in the German, Polish and Dutch studies with 
lower end confidence intervals for specificity approaching or falling below chance.  
 
Middle East (Israel and Turkey) 
One study from each region validated the MoCA differentiating MCI from controls. 
Kaya et al [29] (N=196)  reported education adjusted cutoffs for the MoCA-Turkey, 
however there were high FP rates with specificity around chance level, sensitivity was 
also low for those less educated.  
The MoCA-Hebrew study (N=154)  [57] suggested a cut-off of 26. Education 
adjustments were not used in these studies.  
 
South America (Brazil, Chile, Columbia) 
Two studies (N=168) validated the MoCA differentiating MCI from controls in Brazil 
[58,59] both reporting a cut off of 25 with adequate sensitivity and specificity. One 
study [60] (N=68) validated the MoCA-Chile suggesting a cut off of 24 in an educated 
sample. However the FP rate was high, with wide confidence intervals. In the 
Columbian sample [61] (N=216) suggested a cutoff of 23 in an educated sample with 
adequate sensitivity and specificity. 
Memoria et al. [59] retained the original 1 point adjustment, while Gil et al [61] 
suggested it should be for < 11 years education. 
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Insert Figure 5: Forest plot for studies differentiating between MCI and 
dementia. 
 
Insert Figure 6: Forest plot for studies differentiating between dementia and 
NC. 
 
Dementia vs. NC 
Eighteen studies in total (N=12670) investigated the ability of the MoCA to differentiate 
dementia from NC. Studies, covariates and forest plots are presented in Figure 5. 
Dementia types: Alzheimer’s disease (10), Dementia with Lewy bodies (1), mixed type 
dementia (4), behavioral variant fronto-temporal dementia (1), MCI and dementia - 
MCI+ (1), vascular dementia (1), major NCD (1).  Cutoffs ranged from 13 to 26. 
Sensitivity ranged from 75% (at a specificity of 53%) to 100% (at a specificity of 89%). 
Specificity ranged from 57% (at sensitivity of 75%) to 100% (at sensitivity of 94%).  
 
MCI vs. Dementia 
Seven studies in total (N=1087) investigated the ability of the MoCA to differentiate 
dementia from NC. Studies, covariates and forest plots are presented in Figure 6.   
Cutoffs ranged from 15 to 25. Sensitivity ranged from 81% (at a specificity of 80%) to 
100% (at a specificity of 96%). Specificity ranged from 70% (at sensitivity of 89%) to 
98% (at sensitivity of 96%).  
Heterogeneity  
The studies included in the review are heterogeneous, with different demographic 
samples, recruitment settings, education levels, and variations in study population 
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(e.g. severity of disease and co-morbidities). The study specific cut-offs adjust for the 
above factors within their sample populations. However, there are likely other factors 
such as age, education, spectrum (severity or stage) of the target disorder, operator 
characteristics (for index test and reference standard) and technical features (including 
different versions of the test and item adjustment) that have not been accounted for. 
Diagnostic criteria used will lead to diagnostic variability across studies in identifying 
MCI and subsequently affect the validity and reliability, sensitivity and specificity of the 
MOCA in identifying MCI. 
We assessed potential heterogeneity through visual inspection of risk of bias, 
descriptive data and forest plots. We specified two factors that may contribute to 
heterogeneity explored by relating study level co-variates: quality item - selection of 
patients, and education. These were assessed effect by plotting sROCs by covariate.  
We compared high, unclear and low risk studies for the item, selection of patients, in 
sROC (summary of pairs of sensitivity & specificity in ROC space). These data suggest 
that accuracy varies with selection of studies with high/unclear/low (Figure 7). Studies 
at high risk of bias reported higher level of accuracy than low risk studies and unclear 
studies reported lower accuracy.   
Due to different reporting of education attainment, heterogeneity was assessed 
through visual inspection of forest plot (low to high education). It appeared that there 
was a mild distinction between primary and secondary educated (at the 8 year point). 
Below 8 years there was no clear pattern of improving sensitivity/specificity as 
hypothesized (pooled sensitivity/specificity: 74%/70%). For >8 years sensitivity 
appears stable while specificity fluctuates (pooled sensitivity/specificity: 86%/70%). As 
such there was no clear pattern for the effect of education.   
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Insert Figure 7: sROC curve displaying influence of quality item, selection of patients 
on accuracy. 
 
Discussion  
 
The investigation of the cross cultural applicability of the MoCA in screening for MCI, 
revealed wide variation in cut-offs both across countries and within region and as a 
result it is not possible to conclusively suggest adjusted cut-offs. Apart from China, 
there were a low number of studies, generally only one, validating the measure in each 
region. Many translated forms of the MoCA have not been validated, and there are no 
published studies validating its use in large populations e.g. use in different countries 
in Africa or the Middle East. A number of studies were not considered to display 
adequate sensitivity with high FP rates [29,50,51,54]. However, many of the studies 
indicated adequate to high sensitivity and specificity against study specific cut-offs and 
education adjustments.   
No clear pattern was identified for the effect of education. Years of education may not 
be equivalent across countries, where quality of education varies. Formal educational 
levels will differ between countries, where variation will exist in the organization of 
educational systems, access, learning outcomes and resources (e.g. teachers). 
Indeed, literacy in later life (as a measure of educational quality) is a stronger predictor 
of cognitive performance in older individuals than years of education [62]. In addition, 
certain items on the MoCA are likely to be influenced by education [43], for instance, 
clock drawing, phonemic verbal fluency, and verbal abstraction [59]. 
The reviewed studies were primarily case control studies, with small sample sizes, 
with some validations only carried out for dementia. As expected, the case-control 
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studies (high risk of bias) appeared to over-estimate sensitivity and specificity, with 
studies with unclear risk of bias for selection of patients reporting lower accuracy (than 
low risk studies), possibly indicative of poor methodological quality. Item adjustments 
may also have effected scores with different forms being used across studies, this is 
especially pertinent to China where multiple versions exist. In this review, variation in 
both the diagnostic criteria and operational definitions precluded us from making 
quantitative interpretations of the influence of both factors. However given that these 
variables substantially affect estimation of prevalence rates [11] it is likely that they will 
exert a strong influence on a comparison between studies.     
 
 
A comprehensive review of the literature was conducted with attempts made to obtain 
translations of non-English papers and contact with authors was made where further 
information or additional data were required. Samples from studies conducted in the 
context of different specialist settings were included in this review as they were 
considered to have ecological validity applicable to clinicians in care settings, however, 
it is recognized that this gives rise to heterogeneity. The diversity of countries that have 
studied the MoCA both between and within cultures adds to the generalizability of the 
results. The review does not cover the influence of acculturation and use of interpreters 
which are likely to affect administration and reliability of scores. In a study of 
acculturation effects in North America, high FP rates and lower cut-offs were reported 
(even where English language was proficient) [63]. When using MoCA applicable to 
their country of origin, it’s necessary to consider acculturation (positive and negative 
effects), regional variation e.g. urban/rural, regional language variation and quality of 
education.  
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Given the aging immigrant population across western countries and the anticipated 
increase in dementia prevalence worldwide in coming decades, earlier and more 
accurate detection of MCI in these populations is important. Although the MoCA is an 
effective brief cognitive assessment tool that has shown strong psychometric 
properties in several countries and shows particular advantage in culturally and 
linguistically diverse populations, our results highlight the need for caution when using 
MoCA as a screen for MCI without appropriately accounting for the effects of 
education, language and cultural diversity. Hu et al. [20] found several cultural 
differences in practice in a Chinese version of MoCA. Subjects with lower levels of 
education did not understand how to perform the ‘Alternating Trail Making’ test. This 
has also been reported in a study in subjects from Hong Kong [64]. In the ‘Naming 
tests’, 58.2% of subjects were unable to name the ‘rhinoceros’ and ‘camel’ since the 
animal is not within the realm of their general understanding or vocabulary. In the word 
memory test, the original words are not easy to memorize for Chinese people 
especially the words ‘velvet’ and ‘church’, which fall outside Chinese cultural 
background. In the ‘Abstract thinking’ test the ‘watch’ and ‘ruler’ were only correctly 
remembered by 41.8% of subjects, and even among those of a higher level of 
education they were only correctly identified 50% of the time [20].  
Due to the differences in cultures, further revision is required to tailor the contents 
more accurately to local populations and to highlight the difficulty in separating the 
influence of culture from education level. In immigrant populations additional caution 
should be given to interpretation of scores when using forms for the country of origin 
or English language forms due to acculturation effects.    
It is also necessary to redefine cut-off rates based on age and education-specific 
normative values so that individual test items can be modified appropriately, enabling 
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better content validity (i.e. type and quality of the test items to assess mild 
impairments in cognitive functioning). There is need for future research to provide 
consistent data reporting conventions to facilitate direct comparison across 
countries. Future research, may also make use of education classification systems 
(e.g. International Standard Classification of Education [65] to facilitate more 
accurate cross cultural comparisons of the effects of education. Validations need to 
be carried out on different versions, especially those available on the MoCA website 
as these can appear to be endorsed by the creators.  Further research could also 
explore the effect of acculturation on MoCA performance as this is especially 
pertinent given the aging migratory populations. Identification of salient domains 
which show cultural variability or have greater/less reliability could also inform 
development of MoCA forms for unvalidated populations. 
 
Conclusions 
The findings of this review suggest that it would be more appropriate to use cutoffs 
and point adjustments for education as suggested by validation authors (not those of 
the original paper). The ‘low’ quality of validation papers and likelihood that accuracy 
is over estimated highlighted the need for clinicians and research to use the MoCA 
appropriately, that is, as a brief, cognitive screening tool. Furthermore, it is important 
to stress that test scores should be interpreted in light of other clinical data, such as 
clinical history, collateral information, and behavioral observations [25]. It should be 
noted that although the MoCA has been adapted across languages and cultures, it 
takes little account of acculturation factors. Utilizing cognitive screens can be 
implemented to obtain objective data, however, the review indicates the limitations and 
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suitability of using versions of the MOCA within the context of individual and cultural 
factors.  
 In addition, the reported range of cut-offs in validated papers suggests that there is 
questionable utility in using unvalidated measures and direct translations.   
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Figure 1: PRISMA flow diagram of the systematic review. 
 
 
 
Figure 2: Risk of bias and applicability concerns graph: review authors’ judgments 
about each domain presented as percentages across included studies 
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Figure 3: sROC curve for studies differentiating between MCI and NC. 
 
 
 
Figure 4: Forest plot for differentiating between MCI and NC. a, b indicates education 
or age adjustment within the same study. 
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Figure 5: Forest plot for studies differentiating between dementia and NC. 
 
 
Figure 6: Forest plot for studies differentiating between MCI and dementia. 
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Figure 7: SROC curve displaying influence of quality item, selection of patients on 
accuracy estimates. 
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Figure 1. Risk of bias and applicability concerns summary: review authors' 
judgements about each domain for each included study MCI VS NC 
 
Figure 1. Risk of bias and applicability concerns summary: review authors' 
judgements about each domain for each included study DEMENTIA VS NC 
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